Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Dec;66(12):1456-9.
doi: 10.1001/archneurol.2009.262.

Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies

Affiliations
Review

Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies

Brent R Wright et al. Arch Neurol. 2009 Dec.

Erratum in

  • Arch Neurol. 2010 Apr;67(4):518. Edberg, Dale E [corrected to Edberg, Dale D]
  • Arch Neurol. 2010 Feb;67(2):147

Abstract

Natural autoreactive monoclonal IgM antibodies have demonstrated potential as therapeutic agents for central nervous system (CNS) disease. These antibodies bind surface antigens on specific CNS cells, activating intracellular repair-promoting signals. IgM antibodies that bind to surface antigens on oligodendrocytes enhanced remyelination in animal models of multiple sclerosis. IgM antibodies that bind to neurons stimulate neurite outgrowth and prevent neuron apoptosis. The neuron-binding IgM antibodies may have utility in CNS axon- or neuron-damaging diseases, such as amyotrophic lateral sclerosis, stroke, spinal cord injury, or secondary progressive multiple sclerosis. Recombinant remyelination-promoting IgM antibodies have been generated for formal toxicology studies and, after Food and Drug Administration approval, a phase 1 clinical trial. Natural autoreactive monoclonal antibodies directed against CNS cells represent novel therapeutic molecules to induce repair of the nervous system.

PubMed Disclaimer

Figures

Figure 1
Figure 1. rHIgM22-binding interactions are dependent upon a CST substrate
Images (100x) of O4 (sulfatide; A,G), rHIgM22 (B,H) or MOG (C, I) reactivity shown using live cerebellar sections (200µm) subsequently fixed, FITC immunostained and DAPI counterstained (D–F, J–L). Wild-type showed reactivity to all in contrast cst (−/−) showed MOG but lacked O4 and rHIgM22 reactivity.
Figure 2
Figure 2. Neuron-Binding Antibodies Demonstrate Temperature-Dependent, Surface Membrane Rearrangement
sHIgM42 reactivity shown using live cerebellar granule neurons subsequently fixed, FITC immunostained and DAPI counterstained. sHIgM42 demonstrated binding interactions at 0°C (A) and membrane rearrangements at 15°C (B). Note formation of small punctuate domains along neurites at 15°C but not at 0°C.
Figure 3
Figure 3. Mechanism of NA Monoclonal Antibody-mediated CNS Repair
Pentameric interactions of antibody binding to plasma membrane glycolipids (A) and proteins (B) on live cells induce membrane rearrangements. Signaling molecule (C) activation of pathways including calcium flux, MAP kinase activation and blocking caspase-3 activation that converge on transcriptional regulation of genes promoting CNS protection and repair.

References

    1. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol. 1995 Dec;7(6):812–818. - PubMed
    1. Howe CL, Bieber AJ, Warrington AE, Pease LR, Rodriguez M. Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol Dis. 2004 Feb;15(1):120–131. - PubMed
    1. Paz Soldan MM, Warrington AE, Bieber AJ, et al. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci. 2003 Feb;22(1):14–24. - PubMed
    1. Pirko I, Ciric B, Gamez J, et al. A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. Faseb J. 2004 Nov;18(13):1577–1579. - PubMed
    1. Banks WA, Farr SA, Morley JE, Wolf KM, Geylis V, Steinitz M. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment. Exp Neurol. 2007 Aug;206(2):248–256. - PMC - PubMed

Publication types

MeSH terms